Delhi-based men’s health tech startup RxMen has raised Rs 5 crore (around $570K) in its seed round led by Inflection Point Ventures (IPV). The round also saw participation from SPA Family Ventures, Ankit Goel, Seven Square Ventures, along with a grant from Prosus Group.
The fresh funds will be utilized for brand building, launching RxMen-branded products, and setting up co-branded clinics. The startup is eyeing positive EBITDA by October 2025.
RxMen, founded in 2022 by Shailja Mittal, is a men’s health platform combining clinics and digital care to provide root-cause treatments in sexual health, hormonal balance, skin, stress, and sleep.
In the past 20 months, the startup claims to have grown 100x in revenue, reporting an MRR of $70,000 (Aug 2025) and projecting an ARR of $1.7 million by FY26.
Also Read | Reveal HealthTech Raises $7.2 Mn in Series A Led by Leo Capital
RxMen has already facilitated 30,000+ consultations and manages 6,000 consultations monthly with the support of 30 specialists across urology, psychiatry, sexology, and therapy.
The company has also built a Sexual Health Index (SHI) from 25,000 anonymized consultations, currently under validation at IIT Jodhpur, with a reported 95% success rate in outcomes.
